.../14/20, MRK bought $1 B worth of SGEN stock for $200... SGEN at a comparable basis, MRK would have to pay $263..., had previously worked at MRK. That could favor MRK. The Baker Bros... stockholder. Since MRK'S buy in Sept '20, MRK stock is up 12...%. On the day prior to MRK'S '20 buy of SGEN...

...cardiomyopathy. “Getting Opdualag helped [the stock], but even more important was ...Evan Seigerman, who expects the stock to hit $92, up 19% ...—investors could re-evaluate Bristol stock, which trades at just under ... (JNJ) 17 times, and Merck MRK –2.61% ’s (MRK) 12.7 times. Only Pfizer ...7 times would put Bristol stock at $91.38, up 18% ... Capital Group, which owns the stock. That catalyst is already here, ...

...cardiomyopathy. “Getting Opdualag helped [the stock], but even more important was ...Evan Seigerman, who expects the stock to hit $92, up 19% ...—investors could re-evaluate Bristol stock, which trades at just under ... (JNJ) 17 times, and Merck MRK –2.61% ’s (MRK) 12.7 times. Only Pfizer ...7 times would put Bristol stock at $91.38, up 18% ... Capital Group, which owns the stock. That catalyst is already here, ...

... cardiomyopathy. "Getting Opdualag helped [the stock], but even more important was ... Evan Seigerman, who expects the stock to hit $92, up 19% ...—investors could re-evaluate Bristol stock, which trades at just under ...) 17 times, and Merck's (MRK) 12.7 times. Only Pfizer (....7 times would put Bristol stock at $91.38, up 18% ... Capital Group, which owns the stock. That catalyst is already here, ...

... cardiomyopathy. "Getting Opdualag helped [the stock], but even more important was ... Evan Seigerman, who expects the stock to hit $92, up 19% ...—investors could re-evaluate Bristol stock, which trades at just under ...) 17 times, and Merck's (MRK) 12.7 times. Only Pfizer (....7 times would put Bristol stock at $91.38, up 18% ... Capital Group, which owns the stock. That catalyst is already here, ...

... Exchange Commission filing. On the stock market today, AbbVie stock toppled 4.2% to... at Amgen (AMGN) and Merck (MRK). "I am thrilled to take ... are likely to shake AbbVie stock. AbbVie also won Food and ... shares tumbling, but the pharma stock still remains well above its ...-day moving averages. Bullishly, AbbVie stock also has a Composite Rating ...Rating of 96 means AbbVie stock trades in the leading 4% ...

... Exchange Commission filing. On the stock market today, AbbVie stock toppled 4.2% to... at Amgen (AMGN) and Merck (MRK). "I am thrilled to take ... are likely to shake AbbVie stock. AbbVie also won Food and ... shares tumbling, but the pharma stock still remains well above its ...-day moving averages. Bullishly, AbbVie stock also has a Composite Rating ...Rating of 96 means AbbVie stock trades in the leading 4% ...

@Anonymous The 500 index is always a great passive investment choice. Should note this is 2022, and looking forward MRK looks like a solid individual stock choice, with Keytruda, great pipeline, 3% dividend and improving business fundamentals. Doesn’t matter how things were in 2000. Market is forward, not backward, looking.

@Anonymous The 500 index is always a great passive investment choice. Should note this is 2022, and looking forward MRK looks like a solid individual stock choice, with Keytruda, great pipeline, 3% dividend and improving business fundamentals. Doesn’t matter how things were in 2000. Market is forward, not backward, looking.

A 2 for 1 on stock with either of these companies ... it. 2 for 1 with MRK plays out better for us ...

A 2 for 1 on stock with either of these companies ... it. 2 for 1 with MRK plays out better for us ...

BIG news for MRK. the stage #3 Metastasis news could be huge stock up over $100 this week

BIG news for MRK. the stage #3 Metastasis news could be huge stock up over $100 this week

@tony you know why MRK had an attorney as CEO all those years. My MRK stock is a multi-generational holding and this previously #1 vaccine developer missed the COVID train while they were off chasing social issues. That move cost us 1 generation of value.

@tony you know why MRK had an attorney as CEO all those years. My MRK stock is a multi-generational holding and this previously #1 vaccine developer missed the COVID train while they were off chasing social issues. That move cost us 1 generation of value.

$MRK stock breakout watch https://stockconsultant.com/?MRK

$MRK stock breakout watch https://stockconsultant.com/?MRK

Every single stock in my portfolio is out performing NVDA on a 12 month basis, including AMD, KO and MRK. You can say whatever you want but this is going to take some time to hit bottom and it's going to take several years to get back to 300. That bloated PE was a warning sign that only the smart people realized.

Every single stock in my portfolio is out performing NVDA on a 12 month basis, including AMD, KO and MRK. You can say whatever you want but this is going to take some time to hit bottom and it's going to take several years to get back to 300. That bloated PE was a warning sign that only the smart people realized.